Search Results

You are looking at 1 - 10 of 344 items for :

  • patient experience x
  • Refine by Access: All content x
Clear All
Open access

Espen Nordheim, Jørn Petter Lindahl, Rasmus Kirkeskov Carlsen, Anders Åsberg, Kåre Inge Birkeland, Rune Horneland, Birgitte Boye, Hanne Scholz, and Trond Geir Jenssen

Introduction Transplantation has become an established treatment option for selected patients with type 1 diabetes in many centres. Simultaneous pancreas and kidney (SPK) transplantation was offered to the first patient in history in Minnesota

Open access

Kranti Khadilkar, Vijaya Sarathi, Rajeev Kasaliwal, Reshma Pandit, Manjunath Goroshi, Gaurav Malhotra, Abhay Dalvi, Ganesh Bakshi, Anil Bhansali, Rajesh Rajput, Vyankatesh Shivane, Anurag Lila, Tushar Bandgar, and Nalini S Shah

diagnosis of malignant PCC/PGL is the presence of metastases in the non-chromaffin areas ( 2 ). Metastases in patients with PCC/PGL are commonly diagnosed by anatomical imaging and/or functional imaging ( 3 , 4 ). The latter includes 123 I

Open access

Yuan Liu, Siyi Guo, Jinsong Wu, Rongai Wang, Jinbo Liu, Yan Liu, Bin Lv, Nan Liu, Ling Jiang, and Xiaoli Zhang

H . Clinical characteristics of primary hyperparathyroidism: 15-year experience of 457 patients in a Single Center in China . Frontiers in Endocrinology 2021 12 602221 . ( https://doi.org/10.3389/fendo.2021.602221 ) 21 Wang W Kong J Nie M

Open access

Boni Xiang, Ran Tao, Xinhua Liu, Xiaoming Zhu, Min He, Zengyi Ma, Yehong Yang, Zhaoyun Zhang, Yiming Li, Zhenwei Yao, Yongfei Wang, and Hongying Ye

decreased iodine-131 (I 131 ) accumulation in the thyroid of euthyroid patients ( 3 ). Dexamethasone administration (16 mg daily for 2.5 days) was reported to reduce the thyroid-stimulating hormone (TSH) and free T3 (FT3) secretion and blunted the TSH

Open access

Eva Jakobsson Ung, Ann-Charlotte Olofsson, Ida Björkman, Tobias Hallén, Daniel S Olsson, Oskar Ragnarsson, Thomas Skoglund, Sofie Jakobsson, and Gudmundur Johannsson

understand the origin of their symptoms and signs post surgery ( 17 ). There are few studies focusing on patients with pituitary tumours and their experiences during the different phases of their illness based on their own narratives and, especially, covering

Open access

Pinaki Dutta, Bhuvanesh Mahendran, K Shrinivas Reddy, Jasmina Ahluwalia, Kim Vaiphei, Rakesh K Kochhar, Prakamya Gupta, Anand Srinivasan, Mahesh Prakash, Kanchan Kumar Mukherjee, Viral N Shah, Girish Parthan, and Anil Bhansali

(QoL) (1) . However, successful treatment of acromegaly either by surgery, radiation or combinations of different treatment modalities results in GH deficiency (GHD) in nearly 30–60% of patients (2, 3) . The prevalence of GHD increases as the duration

Open access

Elena Valassi, Iacopo Chiodini, Richard A Feelders, Cornelie D Andela, Margueritta Abou-Hanna, Sarah Idres, and Antoine Tabarin

surgery and multidisciplinary care of comorbidities both pre- and post-cure of CS, including the psychological dimension of the patient’s disease experience ( 10 ). Few data are available about patients’ perceptions of the medical journey from first

Open access

W J Bom, F B M Joosten, M M G J van Borren, E P Bom, R R J P van Eekeren, and H de Boer

studies addressed it only briefly ( 17 , 18 , 19 ). The present study aims to extend the knowledge about the learning curve and reports and compares our initial experience with thyroid RFA with the available literature. Patients and methods This is

Open access

Henghai Huang, Qijian Ding, Xiaocao Lin, Delin Li, Jingjing Zeng, and Weijin Fu

phrenic nerve, the vagus nerve and the sympathetic trunk. Adrenal schwannoma (AS) arises from Schwann cells related to these nerves ( 7 , 8 ). AS is usually benign and slow-growing but can be malignant ( 9 ). AS is mostly asymptomatic, but some patients

Open access

Hanna Karhapää, Siru Mäkelä, Hanna Laurén, Marjut Jaakkola, Camilla Schalin-Jäntti, and Micaela Hernberg

, combination therapy with ipilimumab and nivolumab causes endocrinopathies more frequently than with monotherapies; even up to 50% of patients treated with combination therapy experience endocrine AEs ( 10 ). Numerous algorithms exist for the assessment and